4//SEC Filing
Edwards Larry Todd 4
Accession 0001787306-23-000113
CIK 0001787306other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 9:45 PM ET
Size
7.3 KB
Accession
0001787306-23-000113
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Award
Common Stock
2023-09-27+60,000→ 60,000 total - Award
Stock Option (right to buy)
2023-09-27+240,000→ 240,000 totalExercise: $5.58Exp: 2033-09-27→ Common Stock (240,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units ("RSUs") will vest as to 25% of the RSUs on each annual anniversary of October 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]The option will vest and become exercisable as to 25% of the shares subject to the option on October 1, 2024, and the remaining options will vest at 2.0833% subject to the options on each monthly anniversary thereafter, subject to Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001994805
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 9:45 PM ET
- Size
- 7.3 KB